Hernandez-Bird, J., He, B., VanOtterloo, L. M., Billings, E. B., Huo, W., Teodoro, G. I. C., Echlin, H., Rosch, J. M., Trent, M. S., Isberg, R. R. (2026). Resistance, heteroresistance, and fitness costs drive colistin treatment failure during
                    <i>Acinetobacter baumannii</i>
                    pneumonia. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2515303123